Genetic blockade of the insulin-like growth factor-I receptor: A promising strategy for human pancreatic cancer

Cancer Research

Volumn 63, Issue 19, 2003, Pages 6432-6441

  Min, Yongfen ^a   Adachi, Yasushi ^a   Yamamoto, Hiroyuki ^a   Ito, Hideto ^a   Itoh, Fumio ^a   Lee, Choon Taek ^b   Nadaf, Sorena ^b   Carbone, David P ^b   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR;

ADENOVIRUS; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CARCINOGENICITY; COLORECTAL CANCER; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULAR CLONING; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL DIVISION; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DNA, COMPLEMENTARY; FEMALE; FLUOROURACIL; GENE THERAPY; HUMANS; MICE; MICE, INBRED BALB C; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0141988681     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer statistics, 2003. CA Cancer J. Clin., 53: 5-26, 2003.
2. Brand, R. E., and Tempero, M. A. Pancreatic cancer. Curr. Opin. Oncol., 10: 362-366, 1998.
3. Henne-Bruns, D., Vogel, I., Luttges, J., Kloppel, G., and Kremer, B. Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy. Hepatogastroenterology, 45: 855-866, 1998.
4. Baserga, R. Oncogenes and the strategy of growth factors. Cell, 79: 927-930, 1994.
5. Sara, V. R., and Hall, K. Insulin-like growth factors and their binding proteins. Physiol. Rev., 70: 591-614, 1990.
6. Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E., et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5: 2503-2512, 1986.
7. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. (Bethesda), 92: 1472-1489, 2000.
8. Baserga, R. The IGF-I receptor in cancer research. Exp. Cell Res., 253: 1-6, 1999.
9. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
10. Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA, 90: 11217-11221, 1993.
11. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-I) and type 1 IGF receptor (Igf1r). Cell, 75: 59-72, 1993.
12. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res., 54: 4848-4850, 1994.
13. Long, L., Rubin, R., Baserga, R., and Brodt, P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res., 55: 1006-1009, 1995.
14. Lee, C. T., Wu, S., Gabrilovich, D., Chen, H., Nadaf-Rahrov, S., Ciernik, I. F., and Carbone, D. P. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res., 56: 3038-3041, 1996.
15. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. USA, 91: 2181-2185, 1994.
16. Li, S., Resnicoff, M., and Baserga, R. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem., 271: 12254-12260, 1996.
17. Burgaud, J. L., Resnicoff, M., and Baserga, R. Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun., 214: 475-481, 1995.
18. D'Ambrosio, C., Ferber, A., Resnicoff, M., and Baserga, R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013-4020, 1996.
19. Dunn, S. E., Ehrlich, M., Sharp, N. J., Reiss, K., Solomon, G., Hawkins, R., Baserga, R., and Barrett, J. C. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res., 58: 3353-3361, 1998.
20. Jiang, Y., Rom, W. N., Yie, T. A., Chi, C. X., and Tchou-Wong, K. M. Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor. Oncogene, 18: 6071-6077, 1999.
21. Reiss, K., D'Ambrosio, C., Tu, X., Tu, C., and Baserga, R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res., 4: 2647-2655, 1998.
22. Adachi, Y., Lee, C. T., Coffee, K., Yamagata, N., Ohm, J. E., Park, K. H., Dikov, M. M., Nadaf, S. R., Arteaga, C. L., and Carbone, D. P. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology, 123: 1191-1204, 2002.
23. Lee, C. T., Park, K. H., Adachi, Y., Seol, J. Y., Yoo, C. G., Kim, Y. W., Han, S. K., Shim, Y. S., Coffee, K., Dikov, M. M., and Carbone, D. P. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer. Cancer Gene Ther., 10: 57-63, 2003.
24. Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., and Korc, M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res., 55: 2007-2011, 1995.
25. Levitt, R. J., and Pollak, M. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells. Cancer Res., 62: 7372-7376, 2002.
26. Hosotani, R., Miyamoto, Y., Fujimoto, K., Doi, R., Otaka, A., Fujii, N., and Imamura, M. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice. Clin. Cancer Res., 8: 1271-1276, 2002.
27. Basso, D., Plebani, M., Fogar, P., Panozzo, M. P., Meggiato, T., De Paoli, M., and Del Favero, G. Insulin-like growth factor-I, interleukin-1 and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes. Int. J. Clin. Lab Res, 25: 40-43, 1995.
28. Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., and Stampfer, M. J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. (Bethesda), 91: 620-625, 1999.
29. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., and Pollak, M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (Wash. DC), 279: 563-566, 1998.
30. Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., and Pollak, M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393-1396, 1998.
31. Quinn, K. A., Treston, A. M., Unsworth, E. J., Miller, M. J., Vos, M., Grimley, C., Battey, J., Mulshine, J. L., and Cuttitta, F. Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem., 271: 11477-11483, 1996.
32. Hoog, A., Kjellman, M., Nordqvist, A. C., Hoog, C. M., Juhlin, C., Falkmer, S., Schalling, M., and Grimelius, L. Insulin-like growth factor-II in endocrine pancreatic tumours. Immunohistochemical, biochemical and in situ hybridization findings. APMIS, 109: 127-140, 2001.
33. Christofori, G., Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369: 414-418, 1994.
34. Simmons, J. G., Pucilowska, J. B., and Lund, P. K. Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors. Am. J. Physiol., 276: G817-G827, 1999.
35. Kleeff, J., Kornmann, M., Sawhney, H., and Korc, M. Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells. Int. J. Cancer, 86: 399-407, 2000.
36. Giehl, K., Skripczynski, B., Mansard, A., Menke, A., and Gierschik, P. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration. Oncogene, 19: 2930-2942, 2000.
37. Nair, P. N., De Armond, D. T., Adamo, M. L., Strodel, W. E., and Freeman, J. W. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2. Oncogene, 20: 8203-8214, 2001.
38. Tanno, S., Mitsuuchi, Y., Altomare, D. A., Xiao, G. H., and Testa, J. R. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res., 61: 589-593, 2001.
39. Yao, Z., Okabayashi, Y., Yutsudo, Y., Kitamura, T., Ogawa, W., and Kasuga, M. Role of Akt in growth and survival of PANC-1 pancreatic cancer cells. Pancreas, 24: 42-46, 2002.
40. Kulik, G., and Weber, M. J. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cell. Biol., 18: 6711-6718, 1998.
41. Matsuda, K., Idezawa, T., You, X. J., Kothari, N. H., Fan, H., and Kore, M. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor. Cancer Res., 62: 5611-5617, 2002.
42. Birbeck, M. S. C., and Wheatley, D. N. An electron microscopic study of the invasion of ascites tumor cells into the abdominal wall. Cancer Res., 25: 490-497, 1965.
43. Buck, R. C. Walker 256 tumor implantation in normal and injured peritoneum studied by electron microscopy, scanning electron microscopy, and autoradiography. Cancer Res., 33: 3181-3188, 1973.
44. Kayahara, M., Nagakawa, T., Ueno, K., Ohta, T., Takeda, T., and Miyazaki, I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer (Phila.), 72: 2118-2123, 1993.